TOBIRA THERAPEUTICS INC's ticker is TBRA and the CUSIP is 88883P101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $2,677,000 | +88.1% | 67,375 | -40.5% | 0.00% | +33.3% |
Q2 2016 | $1,423,000 | +282.5% | 113,329 | +149.3% | 0.00% | +200.0% |
Q1 2016 | $372,000 | -66.3% | 45,468 | -58.6% | 0.00% | -50.0% |
Q4 2015 | $1,105,000 | +187.0% | 109,955 | +176.1% | 0.00% | +100.0% |
Q3 2015 | $385,000 | -36.4% | 39,831 | +13.5% | 0.00% | 0.0% |
Q2 2015 | $605,000 | – | 35,091 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,668,570 | $33,517,000 | 26.73% |
Stonepine Capital Management, LLC | 637,567 | $8,008,000 | 8.21% |
Abingworth LLP | 589,244 | $7,377,000 | 7.72% |
BVF INC/IL | 1,253,401 | $15,743,000 | 3.35% |
Novo Holdings A/S | 2,027,091 | $25,460,000 | 2.67% |
NEXTHERA CAPITAL LP | 75,000 | $942,000 | 0.82% |
BB BIOTECH AG | 468,000 | $5,878,000 | 0.23% |
TFS CAPITAL LLC | 42,404 | $533,000 | 0.10% |
EverPoint Asset Management, LLC | 150,000 | $1,884,000 | 0.04% |
MARSHALL WACE, LLP | 168,769 | $2,120,000 | 0.02% |